Post the verdict, shares of Fortis Healthcare tumbled 20 per cent to Rs 129, from its intra-day high level on the back of heavy volumes. The stock of healthcare facilities provider hit a 52-week high of Rs 161 after the company said the Hon'ble Supreme court of India on Thursday passed a judgement in favour of one of the wholly-owned subsidiaries of the Company viz. Escort Heart Institute & Research Centre Limited (EHIRCL).
At 12:56 pm, the stock recovered some of its lost ground and was trading 7 per cent lower at Rs 145 on the BSE. The trading volumes on the counter more than doubled with a combined 40 million shares, representing 5 per cent of total equity of Fortis Healthcare, changed hands on the BSE and NSE.
According to a PTI report, a bench comprising Chief Justice Ranjan Gogoi and Justice Deepak Gupta held the former Ranbaxy promoters guilty of contempt of court and said they had violated its earlier order by which the sale of their controlling stakes in Fortis Group to Malayasian firm IHH Healthcare was put on hold. CLICK HERE TO READ FULL REPORT
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in